Is It Time to Sell Moderna (MRNA) Stock and Book Profits?
Moderna Stock Rises on Coronavirus Vaccine Deal
Amarin’s Q2 Earnings and Robust 2019 Outlook
Amarin Corporation (AMRN) reported its Q2 2019 earnings yesterday. Here’s how the stock, investors, and peer pharma stocks reacted.